Tampilkan postingan dengan label Pregnancy. Tampilkan semua postingan
Tampilkan postingan dengan label Pregnancy. Tampilkan semua postingan

Minggu, 31 Agustus 2014

Termination of pregnancy



Termination of pregnancy when the unborn child has Spina Bifida and/or Hydrocephalus. An overview on international literature.

Dr. Carla Verpoorten


Reviewing the recent literature on prenatal diagnosis of spina bifida and selective abortion, we can summarise the articles in four categories : actual practice and policy in different countries, the moral and ethical aspects, the legal aspects and a challenge to the actual practice and policy

ACTUAL PRACTICE AND POLICY
Since 1975 prenatal diagnosis of spina bifida became available with routine screening for elevated levels of maternal serum AFP, amniocentesis and in more recent years the widespread availability of ultrasound. The ability to assess the severity of foetal abnormality at an early stage of gestation enables the parents and the physician to discuss prognosis and make an informed decision regarding termination of the affected pregnancy, which is legal in most states until 24 weeks. Some of these diagnoses are not made until after 24 weeks' gestation. At these late gestations, many physicians are unwilling to perform pregnancy termination, partly because of the possibility of producing a "live-born" neonate. Not all parents faced with a foetal anomaly elect to abort. However, in case in which the parents have elected abortion, the intent is to prevent the delivery of a live-born neonate. Some neonatologists believe that once any potentially viable neonate is separated from its mother, it is independent and thus requires resuscitation regardless of maternal intent. With the intention of preventing the attendant medical, ethical, and legal problems arising from the birth of live-born, anomalous foetuses, intracardiac potassium chloride injection is used to assure stillbirth  in the setting of  medical abortion late in pregnancy.

MEDICAL AND ETHICAL ASPECTS
ENSURING A STILLBORN : THE ETHICS OF FETAL LETHAL INJECTION IN LATE ABORTION                                                                                                                                           
In his article J.C.Callahan argues  for the moral acceptability of using intracardiac KCl injection to ensure that a seriously anomalous foetus will not be live-born. He gives moral arguments supporting lethal injections for anomalous foetuses : the safety of the woman and the interest of the anomalous foots." Late abortions of seriously anomalous foetuses are undertaken precisely because it is decided that if these foetuses were to survive, their lives would be of an unacceptably low quality."

LEGAL ASPECTS
LATE ABORTION AND THE EUROPEAN CONVENTION FOR HUMAN RIGHTS
National abortion laws usually do not allow abortion when a foots is independently viable, i.e. from a gestational age of about 24 weeks.
Foetal anomalies are sometimes detected only in an advanced stage of pregnancy.
National legislatures who want to allow "late" abortion need to account for the protection the foots may derive from the European Convention for the protection of human rights.
Due to rapidly growing developments in prenatal diagnosis, with which treatment methods do not as yet keep step, an initially welcome pregnancy may become unwanted if a severe, incurable disease or handicap is detected. It then depends on the moment of detection, which for several reasons may be not before the third trimester, whether or not, under the standing Abortion Act in the country concerned, an abortion is still allowed


European Convention on Human Rights  and the law in some European countries.
In France , the law allows for a "therapeutic" abortion" to be authorised by two physicians not only if continuation of pregnancy would seriously endanger the health of the woman, but also if it is to be expected that the future child will suffer from a particularly severe abnormality or disease which is considered incurable. There is no limit in terms of gestational age (art L.162-12 code de la Santé publique)
The Belgian code has a prevision which is basically similar. (art. 350,2 code penal)
In the UK not only legislation on abortion for foetal abnormality has been enacted, but also professional guidelines exist. The law is to be found in the Abortion Act as amended by the Human Fertilisation and Embryology Act 1990.
Previously, the upper gestation at which abortion for foetal abnormality could be provided was limited.
Under the amended Abortion Act two medical  practitioners, acting in good faith, may certify that a pregnancy can be terminated at any gestation if..."there is a substantial risk that if the child were born it would suffer from such physical or mental abnormalities as to be seriously handicapped".
The practitioner notifying an abortion after 24 weeks is required to provide a full statement of the medical condition of the foots and should also complete a still birth certificate.
Law and practice in the Netherlands
Abortion is prohibited under art.296 of the Dutch Penal Code.
Only if the abnormalities are of such a nature that "no extra-uterine survival" can be expected  (which means that even after 24 weeks the foots cannot be considered viable), the law would not prohibit termination of the pregnancy.

A CHALLENGE TO PRACTICE AND POLICY
In a recent article on Prenatal Diagnosis and Selective Abortion, Adrienne Asch argues that professionals should re-examine negative assumptions about the quality of life with prenatal detectable impairments an should reform clinical practice and public policy to improve informed decision making. Current data on children and families affected by disabilities indicate that disability does not preclude a satisfying life. Many problems attributed to the existence of a disability actually stem from inadequate social arrangements that public health professionals should work to change.
This article assumes a pro-choice perspective but suggests that unreflective uses of prenatal testing could diminish, rather than expand, women's choices. This critique challenges the view of disability that lies behind the social endorsement of such testing and the conviction that women will or should end their pregnancies if they discover that the foots has a disability trait.
In order make testing and selecting for or against disability consonant with improving life for those who will inevitably be born with or acquire disabilities, our clinical and policy establishments must communicate that it is acceptable to live with a disability as it is to live without one and that society will support and appreciate everyone with the inevitable variety of traits. When our professions can envision such communication and the reality of incorporation and appreciation of people with disabilities, prenatal technology can help people to make decisions without implying that only one decision is right

CONCLUSION : our message to the medical world and the policy makers
The prognosis for children with spina bifida anno 2000 is much better than indicated by Lorber. Professionals should change their pessimistic view on long-term prognosis and need to counsel parents about the full spectrum of impairment in addition to the effects of modern forms of treatment on the outcome of  unborn infants with spina bifida. The pessimistic public opinion has to be changed before we can assure prospective parents that they and their future child will be welcomed whether or not the child has a disability.
If the child with a disability is not a problem for the world, and the world is not a problem for the child, perhaps we can diminish our desire for prenatal testing and selective abortion and can comfortably welcome and support children of all characteristics.







Teen Pregnancy Synopsis



Teen Pregnancy Synopsis

2007-12 IPLAN PRIORITY: 
Reduce the percentage of births to teens in Vermilion County

Teen Births

Live Births
Mother < 20
% of births to teens VC
% of births to teens Illinois
Infant mortality
cases
Infant mortality rate
2004
1079
177
16.4%
9.9%
6
**
2005
1112
180
16.2%
9.7%
11
**
2006
1176
166
14.1%
10.0%
7
**
2007
1117
151
13.5%
10.1%
8
**
2008
1094
164
15.0%
10.0%
9
**
2009
1100
172
15.6%
9.6%
Not avail
**
**number too low to calculate rate

Birth rate for VC teens (by age group)

2005
2006
2007
2008
2009
< 15 yrs of age
3
2
0
4
1
15-17 yrs old
57
56
46
53
54
18-19 yrs old
120
108
105
107
117

COMMENT:  In 2007, teen birth rate was 13.5% which is the lowest it has been since keeping records beginning in 1970.  However, the rate then climbed back to 15.0% and 15.6% respectively in 2008, 2009.   The number of births to VC teens age 15-17 remains consistent (near 50/year) since 2005.  The percent of birth to teens in Vermilion County still remains well over the State rate which tends to remain fairly constant between 9-10%.

2007-12 IPLAN GOAL:
Reduce the percentage of youths reporting sexual intercourse before age 17.

Data below per: I Sing the Body Electric 2010 Survey

  • Vermilion County students who have had sexual intercourse sometime in their life reached the highest percent since data was first collected in 2002. The 2010 number (55.7%) represents an increase of 4.5% from 2002 and an even greater increase of 6.5% from 2008.
  • The 2010 survey shows that 8.5% of VC youth have had sexual intercourse before the age of 13.  This is a 13.3% increase from 2002 numbers (7.5%).
  • In 9th grade VC youth, male students (44.4%) were more likely than female students (37.4%) to have had sexual intercourse sometime in their life.  The reverse is true in 10th, 11th, and 12th grades with female students reporting higher incidences of having had sexual intercourse than males.




ISBE 2010 Survey Data, con’t:

  • Data further indicates that 12.2% of VC males (or one in eight) report having sex before the age of 13, while 4.7% of VC females (or one in 20) report having sex before they turned 13 years old.
  • VC had developed a positive downward trend from 2004 to 2008 in youth reporting multiple partners.  Unfortunately, in 2010, that risk behavior escalated to the highest number (18.3%) since the survey process began in 2002.  In comparing 2010 VC and 2009 USA numbers, we see that a greater percent of VC youth (18.3%) report having had four or more sexual partners than USA youth at 13.8%.

PER:  (CDC: MMWR Jan 20, 2012 / 61(02);25-29)
  • Approximately 400,000 teens aged 5-19 yrs give birth every year in the U.S.
  • The U.S. teen birth rate remains the highest in the developed world
  • Teen mothers are more likely to experience negative social outcomes, including school dropout.
  • Infants of teen mothers are more likely to be low birth weight & have lower academic achievement
  • Daughters of teen mothers are more likely to become teen mothers themselves.

Data from the Pregnancy Risk Assessment Monitoring System (PRAMS) collected in 19 states (Illinois participates in PRAMS), during 2004-2008, for teens aged 15-19, who became pregnant unintentionally & gave birth to a live infant indicated:
(CDC: MMWR Jan 20, 2012 / 61(02);25-29)

         50.1% reported doing nothing to prevent pregnancy
         Of these teens, 31.4% thought they could not get pregnant at the time 
         23.6% did not use contraception because their partner did not want to use it
         22.1% did not mind getting pregnant








                                                                                                                     

The Management of Ectopic Pregnancy


 

Antenatal Guidelines

No.43   Women who present with early pregnancy pain +/- bleeding,

or early pregnancy loss within EPU dept.



1. Introduction
Women with early pregnancy problems have access to a dedicated Early Pregnancy Unit that provides efficient management , counselling and access to appropriate information.

Facilities of EPU
·         EPU is an outpatient department with an appointment system.
·         The EPU provides a morning only session, Monday to Friday.
·         There are 10 dedicated slots.
·         In addition, inpatients will also be seen as an emergency if deemed appropriate.
·         Access of Beta-hCG assay with results within 24 hours.
·         Rhesus grouping and provision of anti D as appropriate.(see guideline)

Staffing
Gynaecologist/ Obstetrician and Nurse Sonographers
Midwife /MCA
Receptionist

2. Indications for early pregnancy assessment
1. Exclusion of Ectopic pregnancy .
·              Identification of intrauterine implantation
·              Detection of an extra-uterine implantation
2. Confirm ongoing pregnancy in the setting of vaginal bleeding and pain.
3. In presence of hyperemesis requiring hospital admission and treatment
·              Exclude multiple pregnancy and Hydatiditiform Mole
                  pregnancy

3. Reasons for Referral
Women in the first trimester who have had a positive pregnancy test and
1.    abdominal pain
2.    Vaginal bleeding
3.    previous ectopic
4.    previous tubal surgery
5.    Intrauterine contraceptive devise in situ.
6.    Previous Molar pregnancy.
7.    Women referred via the antenatal screening/ dating department.

4. Sources of referral
  1. Gynae SHO/Reg
  2. Emergency Department
  3. Primary Care Doctors
  4. Midwives (in presence of bleeding only)


5. Referral Procedure
Referral bookings are made via the Woman Day Services department within the hours of 0800 -2000, Monday to Friday .Outside these hours the book is held in Maternity Reception (ext 53651)

Details of patients name, date of birth, hospital number (if available), name of person who referred and date of referral  to be recorded and an appointment time given

If the patient is considered to be clinically stable, they are given next available       appointment as outpatient.

If the patient is considered to be clinically unstable and cannot remain in the home setting until the appointment, they must be clinically assessed by the gynae SHO/Reg, who will decide whether there is an indication  for woman to be an inpatient, i.e. in severe pain, bleeding heavily or are unwell.

·         Doctors to advise patients that a Transvaginal scan (TVS) is likely and that as the EPU is an emergency clinic the appointment time and duration  cannot be guaranteed and delays are possible.
·         For TVS the patient will require an empty bladder.
·         Requests for appointments are monitored by midwives to ensure pathways are appropriate.


6. General Management
·         The woman should be welcomed to the unit / ward and sat in appropriate waiting area.
·         The midwife will take a history in a side room to ensure confidentiality and privacy.

The brief  Clinical history includes:
    1. LMP, menstrual cycle ,planned pregnancy / contraception, date of first positive pregnancy test  and previous obstetric history.
    2. abdominal Pain –description
    3. Bleeding –amount and colour. Light / heavy / prolonged
    4. Passage of Products of conception (POC)
    5. Allergies / Medications (check for Latex allergy)
    6. Any previous medical or relevant social history.

  • A urine pregnancy test may be preformed if deemed necessary.
  • Explanations regarding the ultrasound scan are given.
  • The majority of ultrasound scans will be transvaginal in order to optimise images and confirm diagnosis. Patients wishes are respected if strongly declines TVS.
  • A clear explanation is given by the Gynaecologist /Sonographer performing
            the scan regarding the confirmed; possible or likely diagnosis.
  • A plan of management is then formulated . In the case of poor outcomes the patient will be counselled and pathways explained.
  • Blood test are taken as deemed appropriate, and results are reviewed alongside USS reports and clinical history by experienced senior midwives/ nurses  and  seek advice from gynaecologists with specialist interest in EPU if any concerns.
  • Follow up appointments are made as deemed appropriate with appropriate written advise sheets and telephone contact numbers.

N.B.Careful consideration of clinical history, risk factors, ultrasound scan findings and serum BhCG levels and serum progesterone must always be paramount especially in absence of viable ongoing pregnancy.

If the woman appears clinically unstable, i.e. if the woman is bleeding heavily and/or has severe pain, contact Gynae SHO ‘on call’ immediately. Ensure the patient has been stabilised and has IV access  before attempting to scan.


7. Clinical Management
7.1 Viable intrauterine pregnancy
If scan confirms a live intrauterine pregnancy and fetal heart is present the woman may be discharged with general advise to book with midwife.

7.2 Intrauterine pregnancy but unable to confirm viability.

·         Intrauterine sac is <25mm mean sac diameter(MSD) with / without obvious yolk sac.
OR
·         Fetal pole<7 mm crown rump length (CRL) with no obvious fetal heart, Viability cannot be confirmed

N.B. Where the gestational sac is smaller than expected for the gestational age and is less than 25mm(MSD) the possibility of incorrect dates should always be considered, especially in the absence of clinical features of threatened miscarriage.

In order to confirm or refute viability , a repeat scan 14 days later is arranged.
If there is no change in development, ie. Gestational sac/ yolk sac and/or fetal heart have not developed by second scan ,then this confirms diagnosis of missed miscarriage.

If there has been no vaginal bleeding and scan confirms an IU pregnancy  there is no indication for rescan and patient may be discharge and await dating scan.

7.3 Non-viable intrauterine pregnancy
Complete miscarriage  
  • History of heavy PV bleeding with crampy lower abdominal pain and expulsion of  Products of conception (POC)
  • Scan shows empty uterus with endometrial thickness less than 15mm in longitudinal section.  This is a presumptive diagnosis and needs to exclude an ectopic pregnancy unless there has been a previous scan confirming an IU Pregnancy or confirmed passage of POC. If so confirmed then no FU is needed.
  • To check for an ectopic pregnancy take blood to check Serum BhCG and Progesterone and follow guideline for Pregnancy of unknown location.(see below)  
  • Advise re: bleeding and risk of infection. Provide written information leaflet and offer psychological support as needed.

Incomplete Miscarriage
  • Scan shows mixed echogenic Intrauterine tissue with diameter more than 15mm
  • Discuss Management options – expectant / medical and surgical

  • Provide information leaflet and support as above

Missed Miscarriage –
  • If the gestation sac has mean sac diameter (MSD) greater than 25mm ,with no evidence of embryo or yolk sac,
  • If the embryo has a crown rump length greater than 7 mm, with no heart pulsation

Inevitable Miscarriage .
·         Dilated cervix Os with cramping pelvic pains and bleeding. Miscarriage is imminent or in the process of occurring and/or ruptured membranes.


7.3.1 The management pathway options are:
1.Expectant Management.
2.Medical Management:
3.Surgical management


 7.4 Pregnancy of unknown Location (PUL)

Scan shows no signs of either intra- or extra uterine pregnancy with a positive pregnancy test.
  • Ensure serum bHCG and Progesterone is taken and sent to lab.

Review results
  • If BHCG is less than 25iul no further follow up is required.
  • If BHCG is equal or more than 2000iul for review by doctor with EPU interest or Consultant  week on service.
  • Progesterone – if progesterone is equal to or less than 10ng/ml  and BHCG is equal to or less than 500iul – repeat BHCG in 2 weeks
  • Progesterone is equal to or less than 10ng/ml and BHCG is over 500iul – repeat 48-72 hrs
  • If serum progesterone > 10 ng/ml and BHCG over 25iul – repeat 48-72 hrs
  • Rescan if necessary – rising BHCG or static (suspected EP)

N.B. Progesterone level to be done at initial visit only i.e. do not repeat unless specifically  requested by EPU specialist Doctors.


7.4.1 Follow up

Follow up should occur until:
Intrauterine pregnancy identified
            OR
Miscarriage confirmed
            OR
Active intervention required (Ectopic confirmed or persistent suboptimal BhCG level rises)
            OR
BhCG levels falls to less than 25iul.


7.5 Suspected or confirmed tubal ectopic.

In addition, please refer to antenatal guideline 20: Management  of ectopic pregnancy.

8. Fetal heart Auscultated
If clinician is able to auscultate fetal heart and women not in severe/ significant pain then an ultrasound not necessarily indicated.

9. Rh negative women
Give anti-D if necessary – see antenatal guideline 3: Anti-D administration.

10. Notification of outcome
 If viable intrauterine:
  • Send letter and copy of scan to GP. Copy of  letter and scan to be filed in notes.
  • Copy of scan report to patients hand held notes if appropriate

If non viable:
  • Ensure patient have relevant information sheets as appropriate.
  • Complete notification of miscarriage forms.
  • Notify General Practitioner by letter with  copy of scan enclosed. Copy of letter and scan to be filed in notes.

 11. Recurrent Miscarriage
Definition - 3 or more consecutive miscarriages.  May be referred by G.P. to Recurrent Miscarriage Clinic, Ocean Suite.


12. Record Keeping
Ensure all information is filed appropriately in the patients hospital notes. All documentation must  be clear, contemporaneous and  chronological when entered  by any healthcare professionals as per Hospital Trust Policy. This is in keeping with standards set by professional colleges, i.e. NMC and RCOG.

All entries must have the date and time together with signature and printed name.

Monitoring and Audit


Auditable standards:
Patient satisfaction with EPU
Appropriate use of anti-D prophylaxis
Appropriate use of serum hCG / progesterone assessments
Uptake rates for medical / surgical / expectant interventions
Complications of various interventions, i.e. failure rates
Patient choice of treatment
Number of visits to reach definitive diagnosis
Standards of documentation

Please refer to audit tool, location: ‘Maternity on cl2-file11’, Guidelines

Reports to:
Clinical Effectiveness Committee – responsible for action plan and implementation of recommendations from audit

Clinical Governance & Risk Management Committee

Frequency of audit:
Annual

Responsible person:
Womens’ day services manager

 

Cross references

Antenatal Guideline 3 – Administration of Anti-D immunoglobulin

Antenatal Guideline 20 - The Management of Ectopic Pregnancy, Including the use of methotrexate

Antenatal Guideline 31 - Maternity Hand Held Notes, Hospital Records and Record Keeping

Antenatal Guideline 44 – Guideline Development within the Maternity Services

 

References


 

Author

Guideline Committee, Liza Rose

Work Address


Maternity Unit, Derriford Hospital, Plymouth, PL6 8DH

 

Version

3

Changes

Timely update

Date Ratified

Jul 12

Valid Until Date

Jul 15